Asymchem Laboratories (Tianjin) Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Net Sales

1,575.15

1,777.34

1,647.83

1,799.91

1,570.13

1,400.64

1,522.93

Other Operating Income

0.00

Total Operating income

1,575.15

1,777.34

1,647.83

1,799.91

1,570.13

1,400.64

1,522.93

Raw Material Cost

943.26

1,021.60

979.66

1,131.67

881.55

864.62

894.11

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

3.42

3.66

3.07

6.29

1.27

2.11

0.62

Selling and Distribution Expenses

291.95

271.72

209.48

361.08

243.63

234.37

207.24

Other Expenses

15.76

15.05

13.90

12.81

16.13

16.33

17.72

Total Expenditure (Excl Depreciation)

1,396.18

1,447.48

1,331.19

1,627.13

1,287.71

1,264.39

1,279.15

Operating Profit (PBDIT) excl Other Income

179

329.90000000000003

316.6

172.8

282.4

136.3

243.79999999999998

Other Income

60.72

64.65

79.53

206.81

-5.28

150.43

114.56

Operating Profit (PBDIT)

225.25

521.63

519.11

420.46

403.80

397.45

452.05

Interest

3.42

3.66

3.07

6.29

1.27

2.11

0.62

Exceptional Items

1.10

1.38

10.98

34.94

-4.35

4.36

7.86

Gross Profit (PBDT)

631.89

755.74

668.17

668.24

688.58

536.03

628.82

Depreciation

0.00

146.44

145.10

146.97

147.88

137.27

138.35

Profit Before Tax

222.92

372.91

381.92

302.14

250.31

262.44

320.93

Tax

33.35

58.56

34.94

83.97

20.39

27.10

16.47

Provisions and contingencies

0.00

Profit After Tax

199.71

313.86

349.20

258.06

229.81

234.42

306.77

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

199.71

313.86

349.20

258.06

229.81

234.42

306.77

Share in Profit of Associates

0.00

Minority Interest

-3.77

-2.46

-2.18

-3.30

-3.73

-4.61

-2.66

Other related items

0.00

Consolidated Net Profit

195.94

311.40

347.02

254.76

226.08

229.80

304.12

Equity Capital

0.00

Face Value

1.09

1.1

1.07

1.06

1.11

1.07

1.08

Reserves

18,963.75

18,714.93

18,432.28

17,927.06

18,392.07

17,653.07

19,035.82

Earnings per share (EPS)

0.56

0.88

0.96

0.73

0.65

0.69

0.83

Diluted Earnings per share

0.56

0.88

0.96

0.73

0.65

0.69

0.83

Operating Profit Margin (Excl OI)

10.45%

17.47%

17.87%

3.7%

16.64%

7.84%

13.08%

Gross Profit Margin

14.15%

29.22%

31.98%

24.95%

25.36%

28.54%

30.16%

PAT Margin

12.68%

17.66%

21.19%

14.34%

14.64%

16.74%

20.14%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 0.32% vs -17.45% in Sep 2024

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is -13.36% vs -59.64% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -59.79% vs -40.35% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is 161.54% vs 0.00% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of Asymchem Laboratories (Tianjin) Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(HKD)

Change(%)

Net Sales

1,575.15

Other Operating Income

0.00

Total Operating income

1,575.15

Raw Material Cost

943.26

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

3.42

Selling and Distribution Expenses

291.95

Other Expenses

15.76

0.00

15.76

Total Expenditure (Excl Depreciation)

1,396.18

Operating Profit (PBDIT) excl Other Income

178.96

0.00

178.96

Other Income

60.72

Operating Profit (PBDIT)

225.25

Interest

3.42

Exceptional Items

1.10

Gross Profit (PBDT)

631.89

Depreciation

0.00

Profit Before Tax

222.92

Tax

33.35

Provisions and contingencies

0.00

Profit After Tax

199.71

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

199.71

Share in Profit of Associates

0.00

Minority Interest

-3.77

Other related items

0.00

Consolidated Net Profit

195.94

Equity Capital

0.00

Face Value

1.09

0.00

Reserves

18,963.75

Earnings per share (EPS)

0.56

Diluted Earnings per share

0.56

Operating Profit Margin (Excl OI)

10.45%

0.00

10.45%

Gross Profit Margin

14.15%

0.00

14.15%

PAT Margin

12.68%

0.00

12.68%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 157.51 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -11.38% vs 7.86% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 0.32% vs -17.45% in Sep 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 19.59 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -37.09% vs -10.26% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -13.36% vs -59.64% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 16.45 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -64.00% vs 3.96% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -59.79% vs -40.35% in Sep 2024

Quarterly - Interest

Interest 0.34 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is -8.11% vs 19.35% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 161.54% vs 0.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 10.45%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024